Dissecting the earnings of AMD and Intel and excuses made by management, with Mad Money host Jim Cramer.» Read More
Discussing if the small cap run is done and if it's time to buy the dip, with Todd Salamone, Schaeffer's Investment Research, and Lori Calvasina Credit Suisse. Salamone provides his two best small cap picks right now.
Tim Harford, the Financial Times columnist known as the "Undercover Economist," argues that low volatility is very good news for the economy. With CNBC's Jackie DeAngelis and the Futures Now Traders.
Volatility picks up. The 'Undercover Economist,' Tim Harford, weighs in on volatility and the economy, with CNBC's Jackie DeAngelis and the Futures Now Traders.
Back when QE3 started in 2012, Peter Boockvar said it wouldn't help the economy and would cause inflation. He stands by that call. With CNBC's Jackie DeAngelis and the Futures Now Traders.
Gold zooms higher. So what's driving gold now? With CNBC's Jackie DeAngelis and the Futures Now Traders.
The market doesn¿t seem to be sweating the end of QE, but Peter Boockvar, chief market analyst at The Lindsey Group, says it will cause a drop of up to 20 percent. With CNBC's Jackie DeAngelis and the Futures Now Traders.
The Fed is looking at an October date to end quantitative easing. Will it be a scary Halloween for the markets? With Peter Broockvar, The Lindsey Group, CNBC's Jackie DeAngelis and the Futures Now Traders, Scott Nations and Jeff Kilburg, both at the CME.
"Barry and I decided a year and a half ago not to talk about Aereo," CBS CEO Leslie Moonves says.
European debt crisis deja vu is the last thing Wall Street wants, says veteran trader Art Cashin.
U.S. stock index futures indicated a sharply lower open on Thursday.
Indonesian stocks jumped more than 2 percent to one-year highs on Thursday, as investors bet on an election win by Jakarta Governor Joko Widodo.
David Pyott, Allergan chairman and CEO, discusses its restructuring efforts to unlock value for investors and questions the sustainability of Valeant's business model.
In his quest to fend off a hostile takeover attempt, has Allergan CEO David Pyott got something powerful up his sleeve?
If the charts are to be believed, the path of least resistance for these 4 stocks should be higher.
Mad Money host Jim Cramer goes off the charts on biotech's biggest names, Biogen, Regeneron, Gilead and Celgene.
Jim Cramer firmly believes companies can reinvent themselves, provided they have a clear vision and are willing to make tough decisions.
Uncertain how to put money to work in a market that continues to flirt with all-time highs? Jim Cramer has a few ideas. Ten of them.
How to bargain hunt successfully? Mad Money host Jim Cramer looks at the best performers from last quarter.
The Fast Money traders share their final trades of the day.
Niccolo de Masi, Glu Mobile CEO, discusses the development of "Kim Kardashian: Hollywood" and shares a bullish outlook for the app.